Lecture 3.6 Study Guide and Competencies
SARS-CoV-2 and COVID-19
Vocabulary
- Prevalence (of a disease)
- Case fatality rate
- Exponential (growth)
- Zoonotic disease
- Nucleocapsid
- Spike (S) proteins
- Envelope (of a virus)
- Open reading frame
- Replicase/transcriptase complex
- ACE2
- DPP4
- TMPRSS2
Competencies
- Explain the difference between the designations SARS-CoV-2 and COVID-19.
- Explain what SARS-CoV-2 and COVID-19 stand for.
- Explain why prevalence is a more useful measure of risk for getting a disease than is the total number of cases.
- Explain what is technically means to say that something is “exponential,” and explain how to determine mathematically if something is actually exponential.
- Explain how to determine if the epidemic is dying out, staying constant, or increasing.
- Calculate prevalence and use it to compare disease risk in different regions.
- Interpret epidemic data, including cumulative cases, prevalence, and cases in a 5-day moving average.
- Describe how many coronaviruses infect humans, and indicate the severity of the diseases they cause.
- Explain why coronaviruses that infect humans are considered zoonotic.
- Outline the evidence suggesting that SARS-CoV-2 came to the human population through pangolins.
- Describe the basic anatomy of coronaviruses, including N, E and S proteins.
- Outline how the genes of coronaviruses are arranged on the viral ssRNA (single-stranded RNA).
- Compare genome organization of SARS-CoV, SARS-CoV-2 and MERS-CoV.
- Describe the general life cycle of coronaviruses from infection to shedding.
- Compare and contrast the life cycles of SARS-CoV and MERS-CoV.
- Explain the evidence suggesting that SARS-CoV-2 uses ACE2 to enter human cells.
- Explain the evidence suggesting the role TMPRSS2 plays in SARS-CoV-2 infection.